LALPATHLABDr. Lal Path Labs Ltd.
Convert to ideaHealthcare · Healthcare Services · CARE: AA+ (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.1 this quarter.
Momentum from moving averages, Supertrend and RSI.
3 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
3 found · risk watch
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹874 Cr | ₹194 Cr | 26.70% | 22.19% | ₹11.51 | 38.2x |
| Q1 FY2027 | ₹798 Cr | ₹171 Cr | 25.46% | 21.37% | ₹10.15 | 37.3x |
| Q4 FY2026 | ₹703 Cr | ₹132 Cr | 20.24% | 18.81% | ₹7.86 | 27.2x |
| Q3 FY2026 | ₹660 Cr | ₹91 Cr | 20.79% | 13.85% | ₹5.42 | 18.3x |
| Q2 FY2026 | ₹731 Cr | ₹152 Cr | 25.13% | 20.83% | ₹9.03 | 43.4x |
| Q1 FY2026 | ₹670 Cr | ₹134 Cr | 23.54% | 20.01% | ₹7.94 | 39.5x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Services
Compare with peers →Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.